You are here: Welcome » Scott Gottlieb M.D.

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
scott_gottlieb_m.d [2022/04/19 15:02]
pamela 		scott_gottlieb_m.d [2022/11/26 11:56] (current)
pamela
Line 33: Line 33:
 Public Citizen's Health Research Group’s Michael Carome: “Gottlieb Is 'Entangled In An Unprecedented Web Of Big Pharma Ties.'” “’Gottlieb is 'entangled in an unprecedented web of Big Pharmaties,’ Michael Carome, director of the Health Research Group at the advocacy organization Public Citizen, told Public Citizen's Health Research Group’s Michael Carome: “Gottlieb Is 'Entangled In An Unprecedented Web Of Big Pharma Ties.'” “’Gottlieb is 'entangled in an unprecedented web of Big Pharmaties,’ Michael Carome, director of the Health Research Group at the advocacy organization Public Citizen, told
 me.” ((https://www.latimes.com/business/hiltzik/la-fi-hiltzik-gottlieb-fda-20170315-story.html))|Los Angeles Times, 3/16/17 ((https://2n36z24d9zdc4aq2uv1wn19p-wpengine.netdna-ssl.com/wp-content/uploads/2021/12/2021-12-22-Pfizer-Profile.pdf)) me.” ((https://www.latimes.com/business/hiltzik/la-fi-hiltzik-gottlieb-fda-20170315-story.html))|Los Angeles Times, 3/16/17 ((https://2n36z24d9zdc4aq2uv1wn19p-wpengine.netdna-ssl.com/wp-content/uploads/2021/12/2021-12-22-Pfizer-Profile.pdf))
 +
 +==== Revolving Door Career ====
 +
 +F.D.A. Nominee Details Millions in Payments From Drug Firms
 +
 +New York Times - By KATIE THOMAS - MARCH 29, 2017 
 +
 +Dr. Gottlieb was just 33 years old when he became a deputy at the F.D.A. in 2005 during the Bush administration. At the time, he had little government experience beyond a handful of previous stints at the F.D.A. and the Centers for Medicare and Medicaid Services. Before that, he had held jobs as a financial analyst and consultant to the pharmaceutical industry. He also wrote newsletters chronicling the biotech industry: the Gilder Biotech Report and the Forbes Gottlieb Medical Technology Report.
 +
 +Those industry ties soon became a headache. In late 2005, he was forced to recuse himself from discussion of a defense plan for the [[:avian flu]], the Boston Globe reported at the time, because of his consulting work for some of the major players in the vaccine market, including Roche and Sanofi. Around the same time, emails that were leaked to Time Magazine showed him questioning career F.D.A. employees over a decision to halt a trial for a multiple sclerosis drug, and expressing surprise when the agency turned down an osteoporosis drug.
 +
 +At the time, Dr. Gottlieb defended his actions, saying his job required that he ask questions to understand how the agency worked, and that he deferred to career staff on drug approvals.
 +
 +“The agency was being highly politicized by the Bush administration, and he certainly was part and parcel of that politicization,” Dr. Wood said. “I think for that subset of F.D.A. career staff, the physicians who worked there, I think there was suspicion of everyone in leadership at the time.”
 +
 +Dr. Gottlieb left the agency in 2007, and quickly returned to the health care industry. He became a partner at New Enterprise Associates, working on the firm’s portfolio of health care investments, and took consulting work at a range of companies, from pharmaceutical giants like [[:Bristol-Myers Squibb]] and [[:GlaxoSmithKline]] to start-ups like [[:Cell Biotherapy]], an early stage cancer biotech firm that he helped found. Dr. Gottlieb also held seats on a number of corporate boards, including [[:Tolero Pharmaceuticals]], a Utah company working on cancer treatments, and [[:MedAvante]], which assists pharmaceutical companies with clinical trials. ((https://web.archive.org/web/20170329144359/https://www.nytimes.com/2017/03/29/health/fda-nominee-scott-gottlieb-recuse-conflicts.html))
  
  
Line 67: Line 83:
  
 Just think about that for a moment—for years [[:McKinsey]] played both cop and robber. Of course, this is absolutely heinous, and should not have happened. And of course, nobody will be prosecuted. But buried down in the House’s 53-page report((https://web.archive.org/web/20220413130440/https://oversight.house.gov/sites/democrats.oversight.house.gov/files/2022-04-13.McKinsey%20Opioid%20Conflicts%20Majority%20Staff%20Report%20FINAL.pdf)) are a few paragraphs on McKinsey employees emailing that they had influenced a 2018 speech on opioid safety by FDA Commissioner Dr. Scott Gottlieb.((https://disinformationchronicle.substack.com/p/house-investigators-point-to-purdue?s=r)) Just think about that for a moment—for years [[:McKinsey]] played both cop and robber. Of course, this is absolutely heinous, and should not have happened. And of course, nobody will be prosecuted. But buried down in the House’s 53-page report((https://web.archive.org/web/20220413130440/https://oversight.house.gov/sites/democrats.oversight.house.gov/files/2022-04-13.McKinsey%20Opioid%20Conflicts%20Majority%20Staff%20Report%20FINAL.pdf)) are a few paragraphs on McKinsey employees emailing that they had influenced a 2018 speech on opioid safety by FDA Commissioner Dr. Scott Gottlieb.((https://disinformationchronicle.substack.com/p/house-investigators-point-to-purdue?s=r))
 +
 +==== Face The Nation ====
 +
 +Transcript: Dr. Scott Gottlieb on "Face the Nation," Oct. 23, 2022 The following is a transcript of an interview with Dr. Scott Gottlieb, former FDA commissioner and a member of the Pfizer board, that aired Sunday, Oct. 23, 2022, on "Face the Nation."((https://web.archive.org/web/20221023162821/https://www.cbsnews.com/news/scott-gottlieb-transcript-face-the-nation-10-23-2022/))
 +
 +Full transcript of "Face the Nation" on Nov. 6, 2022     
 +Laura Meckler, Dr. Scott Gottlieb and Emily Oster ((https://web.archive.org/web/20221106184329/https://www.cbsnews.com/news/face-the-nation-full-transcript-11-06-2022/))
Back to top